unknown
Stage
About
Aterovax is an in vitro diagnostics company developing blood-based tests for the screening and prevention of cardiovascular diseases. Founded in June 2006, its R&D focuses on cardiovascular biomarkers including sPLA2 and it maintains an international clinical and scientific advisory board.
Explore Aterovax's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.